Please login to the form below

Not currently logged in
Email:
Password:

MOVe-AHEAD trial

This page shows the latest MOVe-AHEAD trial news and features for those working in and with pharma, biotech and healthcare.

Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention

Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention

The MOVe-AHEAD trial will test whether the drug prevents infection in those living in the same household as someone with confirmed COVID-19. ... The second stage of the MOVe-OUT trial – a global phase 3, placebo-controlled, double-blind, multi-site

Latest news

  • Bayer, Merck’s high-risk heart failure drug comes good in phase 3 Bayer, Merck’s high-risk heart failure drug comes good in phase 3

    In 2016 they opted to move ahead with the phase 3 trial despite  mixed results in the phase 2 SOCRATES-REDUCED trial. ... added. At the moment there are no studies involving SGLT2 inhibitors that have competed in worsening heart failure, he suggested

  • Neoantigen player Achilles gets OK for first clinical trial Neoantigen player Achilles gets OK for first clinical trial

    The Stevenage, UK biotech is developing personalised T cell therapies targeted at clonal ‘neoantigens’ – antigens that are found in cancerous but not healthy tissues – and will now move ahead with a ... hopes to start a second trial in advanced

  • Biogen hands out $120m upfront for Remedy stroke drug Biogen hands out $120m upfront for Remedy stroke drug

    Undeterred, Remedy sought a meeting with the FDA that not only gave the go-ahead for the start of the firm's phase III CHARM trial, but has also granted orphan ... category. And with its own portfolio of central nervous system drugs, Biogen has the

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....